Patients with heterozygous variants in BRCA1 or BRCA2 and patients with tuberous sclerosis are comparable to oncology patients (p > 0.091) and are more sensitive to radiation than healthy individuals (p < 0.049) (Figure 2C) [13, 14]. Here, BRCA1 is linked to tuberous sclerosis.